CLARENCE, N.Y.--(BUSINESS WIRE)--Greatbatch, Inc. announced the company has engaged Abel Ang as senior advisor to Greatbatch President and CEO, Thomas J. Hook. In that role, Ang will provide guidance relative to the commercialization of QiG medical device technologies into the health care markets of emerging countries and also help to advise on Greatbatch’s expansion into Asia.
“In 2008, Greatbatch launched a strategy to move our company forward and evolve from not only being an innovative component manufacturer but also being an innovative medical device company,” said Thomas J. Hook, President and CEO. “Abel’s background and experience will serve the company well as we continue our evolution and look to partner with entities in emerging markets to execute our strategy.”
Abel Ang was formerly President, Asia/Pacific for Hill-Rom Inc, a medical devices company, where he was responsible for expanding Hill-Rom’s presence in the high growth Asia/Pacific markets. He previously served as the Chief Technology Officer for Hill-Rom, where he had overall responsibility for Hill-Rom’s global R&D operations distributed across sites in the U.S., Mexico, France, and Singapore. He was also Vice-President and General Manager of Hill-Rom’s $420M Global Surfaces and Therapy Business Unit in addition to other business development positions with the company.
Prior to joining Hill-Rom, Ang headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board’s (EDB) Biomedical Division and spent several years in EDB’s European Operations based in Frankfurt, Germany. He currently sits on the Board of Exploit Technologies which provides access to Singapore's largest pool of intellectual property and knowledge generated by over 2,000 researchers at A*STAR's research institutes, and on the Advisory Board of the Singapore-MIT Alliance Innovation Grant.
About Greatbatch, Inc.
Greatbatch, Inc. (NYSE: GB) provides top-quality technologies to industries that depend on reliable, long-lasting performance through its brands Greatbatch Medical, Electrochem and QiG Group. Greatbatch Medical develops and manufactures critical medical device technologies for the cardiac, neurology, vascular and orthopaedic markets. Electrochem designs and manufactures battery and wireless sensing technologies for high-end niche applications in the energy, military, portable medical, and other markets. The QiG Group empowers the design and development of new medical devices for our core markets. Additional information about the Company is available at www.greatbatch.com.